Concordare Trials
New York, United States
◆ About Concordare Trials
Converts static clinical trial protocol PDFs into structured, interoperable digital formats for clinical research systems.
◆ What sets it apart
It creates a single machine-readable source of truth from any protocol PDF, then automatically generates the operational documents and workflows needed to run the trial.
◆ Sectors
◆ Business
ModelSaaS
CustomerClinical trial sponsors, research sites, hospitals, and clinical operations teams
◆ Notable
- Built the Concordare Suite and proprietary CTPM digital protocol model
- Deployed at Rutgers
- Raised seed funding in 2026
- Selected for accelerator programs including AlphaLab and Techstars Global
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Concordare Trials do?
Converts static clinical trial protocol PDFs into structured, interoperable digital formats for clinical research systems.
Where is Concordare Trials based?
Concordare Trials is based in New York, United States, founded in 2024.
Who has invested in Concordare Trials?
Investors in Concordare Trials include Innovation Works, AlphaLab, NYU School of Medicine and Techstars Global.